Aymee Robainas Barcia

Dr. Aymee Robainas Barcia

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 April 2026 in Microorganisms
Verified
Journal Article
Open access
PDF file
ACAdrià Cruells
Adrià Cruells
CECristina Eguren
Cristina Eguren
ABAymee Robainas Barcia
Aymee Robainas Barcia
HMHelena Martínez
Helena Martínez
MSMohammed Sharaf
Mohammed Sharaf
AGAurora Guerra-Tapia
Aurora Guerra-Tapia
This study assessed the impact of a topical phytocomplex on the acne skin microbiota, encompassing bacterial, fungal, and phage communities. Skin samples obtained from participants exhibiting a positive response to the treatment were analyzed using high-throughput sequencing and bioinformatic approaches including taxonomic profiling, metagenome assembly, functional annotation, and phage identification. Results showed that after treatment, microbial diversity increased, reflecting a more balanced microbial composition. Cutibacterium acnes levels were reduced, particularly virulent IA1/IA2 phylotypes, whereas non-pathogenic or unclassified strains increased. Opportunistic pathogens such as Klebsiella pneumoniae were no longer detected, and beneficial genera including Psychrobacter and Dermabacter were enriched. Functional analysis showed reduced virulence- and biofilm-related pathways, alongside enhanced tryptophan metabolism, SCFA production, lipid synthesis, and riboflavin and folate biosynthesis. Fungal populations, dominated by Malassezia, became more evenly distributed, with notable post-treatment reductions in M. arunalokei, Exophiala spinifera, and Wickerhamomyces anomalus. Phage populations mirrored bacterial changes, with enrichment of Cutibacterium-associated phages post-treatment. These findings demonstrate that the phytocomplex promotes functional rebalancing of the skin microbiota by reducing pathogenic features while maintaining ecosystem stability. The inhibition of quorum sensing, potentially mediated by N-acyl-homoserine lactone acetylation, emerged from metabolic pathway annotation as a hypothetic key mechanism impairing bacterial communication and virulence associated with acne vulgaris.

26 February 2026 in Cosmetics
Verified
Journal Article
Open access
PDF file
HMHelena Martínez
Helena Martínez
MLMaria Lajarin
Maria Lajarin
EMEster Moreno
Ester Moreno
LMLaia Montell
Laia Montell
ABAymee Robainas Barcia
Aymee Robainas Barcia
CNCarlos Nieto
Carlos Nieto
Acne vulgaris remains a common condition, with current topical therapies often limited by suboptimal efficacy and tolerability. This study evaluated the efficacy and safety of two novel 1% hydrogen peroxide (H2O2) formulations, a cream-gel for facial and a sprayable lotion for truncal mild-to-moderate acne. 42 participants presenting facial acne and 41 with truncal acne were treated twice daily for 8 weeks. Efficacy was assessed using the Investigator’s Global Assessment (IGA), the Spanish Acne Severity Scale (EGAE), and lesion counts. After 56 days, facial acne severity improved significantly (IGA −26%, p = 0.01; EGAE −31%, p = 0.01), with reductions in papules (−45%, p = 0.017), porphyrin count (−27%, p = 0.04), sebum production (−75%, p = 0.005), erythema (−35%, p = 0.0001), and desquamation (−22%, p = 0.02). Truncal acne severity also improved significantly (IGA −32%, p = 0.001; EGAE −45%, p = 0.001), with reductions in inflammatory lesions (−60%, p = 0.001), porphyrin size and count (−55% and −48%, both p = 0.001), erythema (−7%, p = 0.005), and desquamation (−27%, p = 0.001). Both formulations were accepted by the users, with minimal local irritation and high patient satisfaction. Topical 1% H2O2 formulations demonstrated significant and well-tolerated efficacy in both facial and truncal acne, supporting their potential as safe and patient-friendly options for managing mild-to-moderate acne.

21 January 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
HMHelena Martínez
Helena Martínez
MLMaria Lajarin
Maria Lajarin
EMEster Moreno
Ester Moreno
LMLaia Montell
Laia Montell
ABAymee Robainas Barcia
Aymee Robainas Barcia
CNCarlos Nieto
Carlos Nieto
Acne vulgaris remains a common condition, with current topical therapies often limited by suboptimal efficacy and tolerability. This study evaluated the efficacy and safety of two novel 1% hydrogen peroxide (H₂O₂) formulations, a cream-gel for facial and a sprayable lotion for truncal mild to moderate acne. 42 participants presenting facial acne and 41 with truncal acne were treated twice daily for 8 weeks. Efficacy was assessed using the Investigator’s Global Assessment (IGA), the Spanish Acne Severity Scale (EGAE), and lesion counts. After 56 days, facial acne severity improved significantly (IGA −26%, p=0.01; EGAE −31%, p=0.01), with reductions in papules (−45%, p=0.017), porphyrin count (−27%, p=0.04), sebum production (−75%, p=0.005), erythema (−35%, p=0.0001), and desquamation (−22%, p=0.02). Truncal acne severity also improved sig-nificantly (IGA −32%, p=0.001; EGAE −45%, p=0.001), with reductions in inflammatory lesions (−60%, p=0.001), porphyrin size and count (-55% and −48%, both p=0.001), ery-thema (−7%, p=0.005), and desquamation (−27%, p=0.001). Both formulations were ac-cepted by the users, with minimal local irritation and high patient satisfaction. Topical 1% H₂O₂ formulations demonstrated significant and well-tolerated efficacy in both fa-cial and truncal acne, supporting their potential as safe and patient-friendly options for managing mild to moderate acne.

16 September 2026 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
CSCarmen Maria Salavastru
Carmen Maria Salavastru
ÁHÁngela Hernández-Martín
Ángela Hernández-Martín
SBSanja Bulut
Sanja Bulut
LFLaura Fernandez Fajardo
Laura Fernandez Fajardo
ABAymee Robainas Barcia
Aymee Robainas Barcia
MLMaria Lajarin
Maria Lajarin
Background/Objectives: Scabies is a highly contagious parasitic skin infestation in which mite infestation, epidermal barrier disruption, secondary bacterial infection, and local inflammation collectively contribute to disease burden. This study investigated whether disulfiram, a component of a fixed-dose benzyl benzoate formulation, may provide local biological activity relevant to scabies-associated complications. Methods: Ex vivo permeation of the formulation was assessed in dermatomed porcine skin, with disulfiram retention in the stratum corneum and dermatomed skin measured against minimum inhibitory concentrations (MICs) for Staphylococcus aureus and Streptococcus pyogenes. Cytotoxicity of the formulation was evaluated in HEK001 keratinocytes across tested concentrations. In vitro antibacterial activity of disulfiram was tested against both Gram-positive species. Transcriptomic profiling was performed on keratinocytes exposed to the formulation. Results: Benzyl benzoate permeation was measurable in the ex vivo model, whereas disulfiram was not detected in the receptor phase under the experimental conditions. Disulfiram was retained in the stratum corneum and dermatomed skin at concentrations exceeding the MICs observed against S. aureus and S. pyogenes. The formulation was not cytotoxic in HEK001 keratinocytes at any tested concentration. Disulfiram showed in vitro antibacterial activity against both Gram-positive species. Transcriptomic profiling identified differential expression of genes involved in oxidative stress responses, detoxification, glutathione metabolism, innate immune signaling, and inflammatory mediator regulation. Conclusions: These findings support a mechanistic rationale for disulfiram as a locally retained component with potential therapeutic relevance to bacterial infection and keratinocyte inflammation in scabies.